Skip to main content
. 2019 Jul 1;11:5983–6001. doi: 10.2147/CMAR.S207084

Table 1.

Correlation of Linc00460 expression with clinicopathological features in 42 breast cancer patients

Expression of Linc00460
Parameter Low(%) High(%) P-value
Age (years) 0.533
 <55 8 (44.4%) 10 (55.6%)
 ≥55 13 (54.2%) 11(45.8%)
Tumor size (mm) 0.030
 <25 13(68.4%) 6 (31.6%)
 ≥25 8 (34.8%) 15 (65.2%)
Tumor stage 0.041
 Ⅰ 9 (75.0%) 3 (25.0%)
 Ⅱ-Ⅳ 12 (40.0%) 18 (60.0%)
ER status 0.002
 Positive 16 (72.3%) 6 (27.7%)
 Negative 5 (25.0%) 15 (75.0%)
PR status 0.513
 Positive 8 (57.1%) 6 (42.9%)
 Negative 13 (46.4%) 15 (53.6%)
HER2 status 0.757
 Positive 9 (47.3%) 10 (52.7%)
 Negative 12 (52.2%) 11 (47.8%)